Jasper Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Retrieved on: 2022-03-11 01:34:10

Tags for this article:

Life Sciences

Branches of biology

Emerging technologies

Communication

Forward-looking statement

Cell therapy

Stem-cell therapy

Hematopoietic stem cell transplantation

Jasper Therapeutics Inc.

Click the tags to see associated articles and topics

Jasper Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference. View article details on HISWAI: https://www.bakersfield.com/ap/news/jasper-therapeutics-to-participate-in-the-oppenheimer-32nd-annual-healthcare-conference/article_1092d083-304e-5d10-b144-2cfc6de4912a.html

Excerpt

REDWOOD CITY, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on ...

Article found on: www.bakersfield.com

View Original Article